Table 3.
B Coefficient | SEβ | P value | |
---|---|---|---|
| |||
Model 1: Demographics | |||
Adj. R2=15% | |||
| |||
Caucasian race | −0.73 | 0.31 | 0.02 |
Household income | 0.49 | 0.30 | 0.10 |
Single parent household | 0.47 | 0.36 | 0.19 |
| |||
Model 2: Model 1 + Disease-specific characteristics | |||
Adj. R2=17% | |||
| |||
Caucasian race | −0.86 | 0.30 | 0.006 |
Basal-bolus insulin therapy | 0.75 | 0.31 | 0.02 |
Pre-mixed insulin therapy | 0.85 | 0.40 | 0.04 |
Adolescent-reported Adherence (C-SCI) | −0.40 | 0.32 | 0.21 |
| |||
Model 3: Model 2 + Adolescent-level variables | |||
Adj. R2=16% | |||
| |||
Caucasian race | −0.75 | 0.33 | 0.03 |
Basal-bolus insulin therapy | 0.78 | 0.32 | 0.02 |
Pre-mixed insulin therapy | 0.87 | 0.40 | 0.03 |
Cognitive development score (PPVT) | −0.006 | 0.007 | 0.40 |
| |||
Model 4: Model 3 + Family-level variables | |||
Adj. R2=18% | |||
| |||
Caucasian race | −0.85 | 0.35 | 0.02 |
Basal-bolus insulin therapy | 0.86 | 0.32 | 0.01 |
Pre-mixed insulin therapy | 0.73 | 0.41 | 0.08 |
Adolescent responsibility for T1D management (DFRQ; adolescent report) | −0.58 | 0.68 | 0.40 |
Adolescent responsibility for T1D management (DFRQ; parent report) | 0.62 | 0.86 | 0.47 |
Parent expression of opinion during T1D discussion (DMIS; adolescent report) | −0.02 | 0.22 | 0.93 |
Parent expression of opinion during T1D discussion (DMIS; parent report) | 0.28 | 0.22 | 0.21 |
| |||
Final Model | |||
Adj. R2=17% | |||
| |||
Caucasian Race | −0.86 | 0.30 | 0.006 |
Basal-Bolus insulin therapy | 0.75 | 0.31 | 0.02 |
Pre-mixed insulin therapy | 0.85 | 0.40 | 0.04 |
Note: For each step, non-significant findings were dropped from the model. Bold values indicate significance at p < .10.